(Q42818439)

English

Adjuvant immunotherapy using fibroblasts genetically engineered to secrete interleukin 12 prevents recurrence after surgical resection of established tumors in a murine adenocarcinoma model

scientific article published on March 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Adjuvant immunotherapy using fibroblasts genetically engineered to secrete interleukin 12 prevents recurrence after surgical resection of established tumors in a murine adenocarcinoma model (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Matsumoto G

1

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Sunamura M

2

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Shimamura H

3

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Kodama T

4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Hashimoto W

5

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Kobari M

6

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Kato K

7

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Takeda K

8

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Yagita H

9

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Okumura K

10

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Hamada H

11

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Matsuno S

12

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

language of work or name

1 reference

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

125

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

257-264

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Endogenous retroviruses lead to the expression of a histocompatibility antigen detectable by skin graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2899%2970235-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0039-6060(99)70235-7

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42818439&oldid=1971075633"